2022 Update and Future of Head and Neck Cancer

We have changed this from an in-person event to a virtual event. This event will now be entirely virtual via Zoom Webinar. Any Questions? Email brittany.gallagher@inova.org 

2022 Update and Future of Head and Neck Cancer is a half-day, comprehensive event that offers premier education and the opportunity to connect in-person with nationally recognized faculty. This course will cover immunotherapy and proton radiation in the treatment of head and neck cancer, as well as surgical approaches for early glottic cancer,  tobacco harm reduction,  management of cutaneous squamous cell carcinoma, HPV vaccinations, and sentinel lymph node biopsy versus neck dissection. Primary care physicians, otolaryngologists, surgeons, speech-language pathologists, and advanced practice providers are all invited to attend.

This Event is Intended for the Following: 

• Oncologists 
• Otolaryngologists 
• Primary care physicians 
• Oral surgeons 
• Advanced practice providers 
• Speech-language pathologists

AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA

Program Directors: 

Gopal Bajaj, MD, MBA, FASTRO
Co-Director, ISCI Head and Neck Oncology Program
President, Radiation Oncology
Associates, PC Inova
Schar Cancer Institute

John Deeken, MD
Co-Director, ISCI Head and Neck Oncology Program
President, Inova Schar Cancer Institute

Heath F. Dreyfuss, MD
Inova System Section Chief—Otolaryngology
Partner, ENT and Facial Plastic Surgery

Patty Lee, MD, FACS
Otolaryngology-Head and Neck Surgery
Otolaryngology Associates
Tumor Board Chair,
Head and Neck Oncology
Inova Schar Cancer Institute

Questions?  Please contact CME@inova.org